Veradigm | MDRX - Passività Correnti





Passività Correnti Cambiamento Data
Alcidion AUD 22.33M 1.47M 2025-12
Ambu A/S DKK 1.32B 209M 2026-09
Amplifon EUR 738.21M 852.39M 2026-06
Cardinal Health USD 46.33B 2.42B 2026-09
Centene USD 39.07B 1.69B 2026-09
Charles River Laboratories USD 1.09B 45.49M 2026-09
Cigna USD 56.03B 471M 2026-09
Coloplast 7.93B 1.42B 2025-12
Convatec Group USD 512.3M 130.7M 2024-12
CVS Health USD 93.1B 6.06B 2026-09
Diasorin EUR 420.55M 134.9M 2026-06
Elevance Health USD 46.66B 2.41B 2026-09
General Electric Aerospace USD 42.4B 1.96B 2026-09
Gulf Medical Proj AED 299.43M 128.34M 2026-03
Humana USD 24.05B 1.05B 2026-09
IQVIA Holdings USD 7.78B 1.04B 2026-09
Laboratory Of America USD 2.82B 695M 2026-09
Max Healthcare Institute Limited 24.93B 3.06B 2026-09
Maximus USD 678.07M 3.62M 2026-06
McKesson USD 74.4B 4.04B 2026-09
Med Life RON 929.7M 46.35M 2026-03
Molina Healthcare USD 7.39B 306M 2026-09
Omnicell USD 473.7M 26.26M 2026-09
Oriola-kd EUR 627.8M 21.9M 2026-09
Owens Minor USD 671.5M 5.28M 2026-09
Quest Diagnostics USD 1.83B 46M 2026-09
Rede D'or Sao Luiz BRL 23.59B 3.85B 2026-09
Siemens Healthineers EUR 13.22B 346M 2026-09
Sonova Holding CHF 1.5B 303M 2025-06
Supermax Corporation Bhd MYR 399.89M 64.12M 2026-06
UnitedHealth USD 115.84B 4.02B 2026-09
Veeva Systems USD 1.46B 245.82M 2026-06
Veradigm USD 230.31M 22.78M 2022-12
Xerox USD 3.2B 75M 2026-09